Witryna2 dni temu · mRNA-1020/1030, a seasonal vaccine candidate that includes neuraminidase antigens to target more conserved regions of the virus. The … Witryna13 kwi 2024 · Management intends to spend $6-$8 billion in additional R&D over the next few years. Concurrently, management provided an update on the seasonal influenza …
Moderna expects Covid, RSV, flu shot sales up to $15 billion in …
Witryna17 sty 2024 · Moderna Announces mRNA-1345, an Investigational Respiratory Syncytial Virus (RSV) Vaccine, Has Met Primary Efficacy Endpoints in Phase 3 Trial in Older … Witryna28 lut 2024 · Meanwhile, Pfizer has tested its RSV vaccine in pregnant people to see whether the protection can pass to babies in utero. The company said its data … german face spray
Moderna Announces mRNA-1345, an Investigational Respiratory …
Witryna15 lut 2024 · Moderna has announced topline results for its mRNA-based vaccine against respiratory syncytial virus (RSV) infection in adults 60 years of age and older. mRNA-1345 targets the RSV fusion... Witryna11 kwi 2024 · Since 2024, pork producers have been using customizable mRNA-based “vaccines” on their herds. The very first RNA-based livestock vaccine, a swine influenza (H3N2) RNA shot licensed in 2012, was developed by Harrisvaccines. The company followed up with an avian influenza mRNA shot in 2015. Harrisvaccines was acquired … Witryna8 paź 2024 · RSV vaccine for young children (mRNA-1345) Human metapneumovirus (hMPV) and parainfluenza virus type 3 (PIV3) vaccine (mRNA-1653) COVID-19 … christine sherrill